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Intraleukocytic monosodium urate (MSU)  1 and calcium pyrophosphate dihydrate 
(CPPD)  crystals are a  constant feature of acute gout and pseudogout, respectively 
(1-3) ; phagocytosis of both types of crystal occurs rapidly in vitro when crystals are 
incubated with human buffy coat leukocytes, and is often seen in wet smears prepared 
from exudate aspirated from affected joints (2). Exudative leukocytes from joints of 
volunteers  injected  with  synthetic  MSU  or  CPPD  crystals contain  phagocytosed 
crystals, which  appear identical by light microscopy with  those found  during  the 
natural attack (3-5). As observed with phase-contrast and polarized light microscopy, 
a  substantial number of CPPD  crystals lie within phagosomes (3), but many CPPD 
and all MSU crystals appear free in the cytoplasm (6). 
Recently,  this concept of crystal-cell interaction has been  challenged by Riddle 
et al., who, using electron microscopy, found no limiting membrane surrounding most 
intraleukocytic MSU crystals in  natural gout,  although  a  few  MSU  crystals lying 
within  phagosomes  were  seen  (7).  Phagosomes  were  found  uniformly  when  syn- 
thetic MSU was added to canine buffy coat leukocytes, or in exudate obtained from 
dog joints after crystal injection, and also when natural crystals were phagocytosed 
by human polymorphonuclear leukocytes in Rebuck skin windows (8). Bluhm et al. 
have  also described the  formation of  intraleukocytic crystals de novo when  hyper- 
uricemic joint fluid  or  serum  containing polymorphonuclear leukocytes was  stored 
in the cold for many hours  (9). These findings have led to the hypothesis that the 
primary event in gouty inflammation is the intracellular formation of MSU, phago- 
cytosis representing only a  secondary phenomenon. 
The  studies  reported  here  were  performed  to  explore  an  alternative  ex- 
planation for these observations, i.e., that urate crystals might be phagocytosed 
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and then interact with the phagosomal membrane,  resulting  in their liberation 
into the cytoplasm. Rupture  of phagolysosomes induced in monocytes by silica 
crystals  has  been  described  recently  by Allison et  al.  (10),  and  both  colloidal 
and crystalline silica have been shown to lyse erythrocyte membranes  (11-15). 
Because erythrocytes  provide a  convenient model for the detection  and  study 
of membrane  lysis,  they were used  in the studies  presented here. 
Materials and Methods 
GeneraL--Doubly  siliconized  glassware was used  throughout.  A  modified Hanks'  buffer, 
pH 6.8, was prepared as described by Phelps, except that doubly distilled, deionized water was 
used and the calcium concentration was reduced to 0.23 m~ (16). Penicillin and streptomycin, 
in final concentrations of 50,000  units and  50 mg per liter, respectively, were added  to the 
buffer in all experiments performed at temperatures above 20°C. 
Crystals.--Monosodium  urate monohydrate  (MSU) was prepared according to previously 
published methods (17). Samples of these crystals (30-100/z in diameter) were ground in an 
agate mortar to produce particles 2-6 #  in length. These were heated for 2 hr to 200°C  to 
eliminate any trace of pyrogen or other organic material that may have been trapped during 
crystal growth. 
Calcium pyrophosphate dihydrate  (CPPD)  (triclinic dimorph) was supplied as a gift from 
James R. Lehr, National Fertilizer Development Center, Muscle Shoals, Alabama. Samples of 
these were reduced in length from approximately 100-200/z to 1-20/z by grinding in an agate 
mortar. 
Silicon dioxide crystals (S) were obtained as a gift from the Pennsylvania Glass Sand Corp., 
Pittsburgh,  Pa.,  as  Min-U-Sil  (Pennsylvania  Pulverizing Co.,  Pittsburgh,  Pa.),  1-10 /~ in 
diameter, 99.9% pure Si02. 
Chemicals.-- 
Polyvinylpyridine-N-oxide (PVPNO)  was a generous gift from Dr. E. Grundmann of the 
Institute for Experimental Pathology, Farbenfabriken Bayer AG, 56  Wuppertal  Elberfeld, 
West Germany. 
Heparin sodium  (H)--Liquaemin Sodium;  10,000 units/ml; Organon Inc., West Orange, 
N.J. 
Dextran (D)--Type 200 C; average tool wt 204,000;  Sigma Chemical Co., St. Louis, Mo. 
Polyvinylpyrrolidone (PVP)--Pharmaceutical grade; average tool. wt 40,000; Sigma Chem- 
ical Co., St. Louis, Mo. 
Disodium ethylenediaminetetraacetic acid dihydrate  (EDTA)--Baker Analyzed Reagent, 
Phillipsburg, N. J. 
Ellagic acid dihydrate (EA)--Aldrich Chemical Co., Inc., Milwaukee, Wis. 
Human erythrocytes (RBC).--35 ml of blood from a normal human  volunteer was  drained 
into a 50 ml conical centrifuge tube, containing 1 ml of heparin sodium, through an 18 gauge 
disposable needle, and  7 ml of 6% dextran in isotonic sodium chloride was added. The cells 
were gentiy mixed and then allowed to settle at room temperature for 30 min. The supernate, 
which contained most of the leukocytes and platelets,  was discarded. The RBC  were washed 
three times with Hanks' buffer,  pH 6.8  (centrifugation at 4°C, 400 g). The concentration of 
packed cells was then adjusted with buffer to provide 3 or 6% suspensions. 
Incubations.- 
Tumbling system: Most experiments were performed in 10 X  75 mm glass test tubes, sealed 
with Parafilm-covered corks,  and rotated end over end, using a multipurpose rotator (Arthur 
Lapine Co.), at 3.5 rpm in an incubator  (A. H. Thomas Co., Philadelphia, Pa.) at 37°C. 102  MEMBRANOLYTIC EFFECTS  OF  MICROCRYSTALLINE U-RATE 
Stationary  system: One experiment was performed without mechanical agitation by simply 
adding cells to crystals in the wells of a plastic disposable serology tray. 
Shaking system: One experiment was performed by the addition of 1 ml of cells to 1 ml of 
crystals, with agitation in a Dubnoff metabolic shaker at 12  strokes/rain for 14 hr at 37°C. 
Experiments.- 
Hemolytic e~ect of crystals: In order to determine whether urate and CPPD crystals behaved 
like  silica  and produced hemolysis of human erythrocytes (RBCs),  0.5  ml of the following 
were added to 0.5 ml of a 3% suspension of RBC  in the tumbling system described above, 
yielding a final concentration per milliliter of: S, 2.5 mg; MSU, 10 mg; CPPD, 10 rag. Tubes 
were removed at 1/~, 11/~, 21/~, 31/~, 41/~, 6l/~, and 20~ hr, centrifuged at 400 g for 10 rain at 
4°C, and the supernate was read at 541 nm in a Beckman Spinco model 151 spectrocolorimeter. 
The effect of pH and the concentration of hemoglobin on the observed optical density was 
determined, and a  standard curve was constructed. The results are expressed as a per cent 
of total hemolysis; a 6% suspension of RBC was diluted with two volumes of distilled water. 
Hemolysis  in a stationary system: To determine whether the hemolysis was due to mechan- 
ical effects,  an experiment was performed in  the stationary system described above--final 
concentrations were: RBC, 1.5%,  and silica, MSU, and CPPD, each  10  mg/ml. Incubation 
at  37°C  for  14  hr was performed, and  supernates were processed as  above.  The effect of 
PVPNO (final concentration, 0.05%)  was determined in each instance. 
tten.olytlc  effect of crystal surfaces compared with solutions: In this experiment 1 ml of RBCs 
(final concentration, 1.5%)  was placed in dialysis sacs, which in turn were placed in 13  )<  100 
mm te,~t tubes, each containing 1 ml of buffer.  In one-half of the tubes the crystals, MSU, or 
silica, were placed within the sacs (final concentration, 10 mg per ml); in the remainder, the 
crystah were placed in the buffer surrounding the sacs. Several tubes containing only  RBC 
witbin sacs served as controls. All tubes were tumbled for 14 hr at 37°C. 
Irish ~bition of crystal effect on RBC membranes: The effect of the strong hydrogen acceptor, 
PVPNO, was determined, as it has been described, as an effective inhibitor of the membrano- 
lyric effect of silica (10-12).  PVPNO and the other substances studied were added to the RBC 
and to the crystal suspensions  and incubated for 30 min at 20°C (the final concentration of each 
was 0.25 rag/100 ml, except ellagic acid which was 0.00025 mg/100 ml) ; the RBC  and crystal 
suspensions were  then mixed  and  tumbled for  14  hr  at  37°C.  The  final concentrations of 
RBC and crystals were as listed in the first paragraph of this section. 
Solutions of PVPNO (0.005%)  in Hanks' buffer, pH 6.8, gave an absorption maximum at 
260 r,m  in a  Beckman DU  (Gilford  modification) spectrophotometer; 4 ml of this PVPNO 
solution were added to tubes containing 100 mg of silica, MSU, or CPPD  (dry weight), and 
to 0.4 ml of packed red blood cells. The crystals were suspended by whirling in a vortex shaker, 
and then tumbled for 60 rain,  centrifuged at  1300 g at 4°C  for 15 min, and the OD  of the 
supernatant solution was determined. 
The effect of plasma on the crystal-cell  interaction was determined. MSU crystals (final 
concentration, 10 mg/ml) were opsonized in 50% plasma in Hanks' buffer, pH 7.3, at 37°C 
for 30 min, with frequent mixing using a vortex shaker, centrifuged twice at 1300 g for 10 min 
at 4°C, and resuspended in 2.5%  plasma in Hanks' buffer,  pH 7.3, each time. The opsonized 
crystals were added to an equal volume of RBC, producing final concentrations of:  RBCs, 
2%, silica,  10 mg/ml, and MSU, 5, 3.75, and 2.5 mg/ml.  Controls were processed identically 
with the experimentals but in the absence of plasma. Incubation was  performed in 25  ml 
Erlenmeyer flasks in a I)ubnoff metabolic shaker at 37°C for 16 hr.  Hemoglobin release into 
the supernate was determined as before. 
RESULTS 
Hemolytic Effects of Crystats.--Curves  depicting the time .course of hemolysis 
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inflection and a second, more gradual, slope, Silica crystals produced a marked 
hemolytic effect (curve a), confirming previous reports (11-15); MSU crystals 
exerted similar  but  less  marked  effects (curve b),  whereas  CPPD  showed  a 
lesser and slower effect (curve c). A difference from the hemolysis occurring in 
the samples of RBC  incubated without particles  was  statistically  significant 
immediately for silica and MSU,  and at 2.25 hr for CPPD. Hemolytic effects 
were linear until 1.25 hr for silica and until 3.5 hr for MSU. Thereafter the rates 
of hemolysis in  samples  containing silica and  MSU showed  a  sharp decline, 
although additional hemolysis occurred throughout the period of incubation. 
Curve c, produced by CPPD, and curve d, produced by RBC  incubated with- 
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FIG. 1.  Curves depicting the time course of hemolysis of a 1.5% suspension of human RBC 
in Hanks' buffer, pH 6.8, incubated with (a) silica, (b) MSU, (c) CPPD, (d) control. See text 
for discussion. The cross-bars  in this and other figures  indicate the mean :t=SD; n = 3. 
out particles,  also showed a  very small,  but definite,  steep initial slope.  The 
rate of hemolysis produced by CPPD crystals then proceeded throughout the 
period of incubation,  producing  a  curve which  was  steeper  than  the  second 
phase of the silica and MSU curves. 
Hemolysis  in  a  Stationary  System.--Silica  and  MSU  produced  definite 
hemolysis in  a  system where  any possible mechanical  effect was  minimized. 
Silica was  far more effective than  MSU  (Fig.  2);  the  CPPD  effect was  not 
statistically different from control lysis.  Data  pertaining  to PVPNO  will  be 
presented below. 
Effects  of Crystal  Surfaces  vs.  Urate  and  Silica  Solutions.--Human  RBC, 
separated physically from crystals in a tumbling system, showed no hemolysis 
compared  to  controls.  Hemolysis  occurred  as  expected  when  crystals  and 
RBC were mixed as before (Fig. 3). 
Inhibition  of  Crystal  Effect  on  RBC  Membranes.--Hemolysis  of  human 104  MEMBRANOLYTIC  EFFECTS OF MICROCRYSTALLINE  URATE 
RBC was produced by silica,  monosodinm urate,  and  calcium pyrophosphate 
in the ratio 12:6:1.5,  respectively, as compared to the control (Fig.  1). PVP 
and PVPNO markedly suppressed hemolysis in all groups, including the con- 
trol  (Fig. 4,  a  and b).  This inhibition was identical for both the control and 
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FIG. 2.  Hemolytic effect on RBC produced after 14 hr of incubation in a  stationary system 
designed to reduce mechanical effects to a minimum is shown with microcrystalline silica (S), 
MSU, CPPD, and 100%  (total hemolysis in distilled water), and 0%  (control hemolysis in 
the absence of particles). The hatched bars represent identical preparations with polyvinyl- 
pyridine-N-oxide added in a  final concentration of 0.05%.  See text for discussion, n  =  3. 
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FIG. 3.  Physical separation of human RBC and crystals was accomplished by  placing  the 
former in dialysis bags. After 14 hr of incubation, no significant hemolysis could be detected 
as compared to control (hatched bars). Cells not isolated were lysed (open bars). C:  =  100% 
hemolysis control, C2 =  RBC in dialysis sac, S  =  silica crystals, MSU =  monosodium urate. W.  R.  WALLINGFORD  AND  D.  .]'.  McCARTY  105 
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CPPD  groups,  indicating  that  PVPNO  had  no  inhibitory  effect  on  CPPD 
hemolysis  per  se.  Dextran  and  heparin  inhibited  (approximately  60%)  the 
RBC  lysis due  to  urate,  but  had  no  effect  on  silica,  CPPD,  or  control  lysis 
(Fig. 4  a  and  b).  Ellagic acid  inhibited silica and  MSU,  but  not  control  or 
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FIG. 5. Inhibitory effect of plasma on MSU (final concentrations  of 5, 3.75, and 2.5 mg/ml) 
and  silica-induced hemolysis. Hatched bars represent  incubation of erythrocytes with par- 
ticulates which  had been  opsonized with intermittent mixing at 37°C for 30 min in 2.5% 
plasma and resuspended  in the same. The open  bars represent incubation of erythrocytes 
with crystals suspended in buffer. See text for discussion. 
CPPD,  hemolysis.  EDTA  had  no  effect  on  any  group,  even  when  divalent 
cations were omitted from the buffer. 
The inhibitory effect of PVPNO  was confirmed using the stationary system. 
MSU  and  silica hemolysis were  reduced markedly, but  no  inhibition  of con- 
trol or CPPD  hemolysis was noted (Fig. 2). 
Human  plasma inhibited MSU-  and  silica-induced hemolysis;  its  effect  on 
CPPD  was  not  studied  (Fig. 5).  Hemolysis due  to MSU  was  proportional to W.  R.  WALLINGFORD AND  D.  J.  MCCARTY  107 
the dose of crystals, and the degree of inhibition by plasma was proportional 
to  the  degree  of hemolysis, i.e.,  the  degree  of hemolysis produced by each 
dose of crystals minus the  degree of inhibition by plasma at  that  dose was 
nearly identical. 
Differential adsorption studies demonstrated that silica and MSU crystals 
adsorbed PVPNO, and that CPPD crystals and RBC failed to bind this sub- 
stance  (Fig.  6). 
2.0 
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FIG. 6.  Absorption of PVPNO by silica, MSU, CPPD, and erythrocytes. See text for dis- 
cussion. 
DISCUSSION 
It was first  shown in 1904 by Landsteiner  and Jagic(13), that colloidal silica 
agglutinated  washed  red cells, and that the addition of fresh serum  produced 
lysis. The  importance  of particle size as a determinant  of biological effect was 
first clearly shown  by Harley and Margolis  (14); colloidal silica  less than 3 nm 
in diameter  blocked  the effects of larger colloids but itself had  no effect on 
washed  red cells; colloidal silica 3-7 nm  in diameter  produced  agglutination 
characterized by a prozone, and larger colloids produced  hemolysis. The direct 
hemolytic effect of silica  as contrasted to complement-mediated  silica  hemolysis 
was later shown  to be a function of particle size by Charache  and colleagues; 
large silica colloids  produced direct hemolysis on washed red cells, which was 108  MEMBRANOLYTIC  EFFECTS  OF  MICROCRYSTALLINE IYRATE 
inhibited  by protein,  whereas  small  polymers  produced hemolysis  only after 
excess silica was removed and fresh serum or whole guinea pig complement was 
added  (15). 
An understanding of these phenomena at a molecular level is based on the work of 
Nash et al.,  who suggested that polymers which are extremely weak acids (phenolic 
character),  and  therefore effective hydrogen donors,  are incompatible with  cellular 
membrane  integrity;  on  the  other  hand,  hydrogen acceptors  are  compatible  (11). 
Biomembranes themselves act as hydrogen acceptors by virtue of their protein and 
phospholipid components. The materials studied in this paper may be divided on the 
basis of structural characteristics into two groups: (a) the phenolic hydrogen donors-- 
orthosilicic acid  (pKa ~  10  -1°)  (11),  MSU (pKa2  =  1.78  X  10-1°)  2, and  (possibly) 
ellagic acid;  and  (b)  the hydrogen acceptors--PVPNO, phospholipid,  protein,  and 
CPPD.  Hydrogen  donors  are  polarized  because  the  highly  electrophilic  phenyl 
radical and oxygen and silicon  atoms result in a  shift of the electron cloud relative 
to the hydrogen nucleus, producing a small positive charge. The hydrogen acceptors 
are characterized by unshared  electrons held  tightly by electrophilic atoms, giving 
them a  small  negative charge. The dative bond in PVPNO makes  this molecule a 
hydrogen acceptor with  marked  affinity. The  small  electrostatic  charge developed 
in this manner allows  the  electropositive  hydrogen donors  to bind  to  the electro- 
negative  hydrogen  acceptors.  A  model  system  has  shown  that  the  affinity  of 
silica  for  PVPNO,  phospholipid,  and  protein  is  in  the  ratio  100:80:2  (11).  The 
formation of hydrogen bonds between PVPNO and orthosilicic acid has been shown 
by ultraviolet spectroscopy (18). 
Hydrogen bonds  are  weak  compared  to  covalent  bonds,  and  therefore  require 
donors or acceptors with a number of closely associated subunits (i.e. crystals, colloids, 
polymers, or biomembranes) in order to produce stable complexes,  as exemplified  by 
the DNA double helix.  The affinity of silica  colloids  for biopolymers and biomem- 
branes appears to be a function of particle size, and this affinity appears to determine 
biological effects; monomers are not bound and have no effect,  larger colloids may 
bind proteins  (e.g.  complement)  and  exert blocking effects; still larger colloids will 
bind red cell-to-red cell; and, finally, at a critical size the silica particle will produce 
sufficient  distortion  of  the  membrane  to  allow leaks.  That  spherocytosis precedes 
hemolysis by larger colloids was first noted by Charache and colleagues (15), and sug- 
gests  that hemoglobin release is preceded  by a  phase in which the membrane be- 
comes freely permeable to cations, which results in swelling and, ultimately, in lysis. 
This mechanism of hemolysis has been documented by vitamin A, although some con- 
troversy still  exists as to whether or not osmotic stabilizers  such as sucrose inhibit 
lysis (19, 20). 
Our  observations  are  consistent  with  the  above  considerations.  PVPNO 
binding  clearly suggests  that  silica  and  urate  are  hydrogen  donors  and  that 
red cells and CPPD are not. As expected, urate-produeed hemolysis and silica 
hemolysis  were  again  confirmed,  but  unexpectedly  CPPD  produced  a  small 
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degree of hemolysis. The lack of PVPNO inhibition of CPPD  hemolysis sug- 
gests  that  this  effect is  not mediated by hydrogen bonds;  furthermore,  the 
difficulty encountered  in  the  production  of  uniformly small  CPPD  micro- 
crystals suggests  that  the hemolysis produced by this compound may be re- 
lated to the impact of hard particles on red cell membranes. 
The  absence of hemolysis when red cells  were separated from crystals by 
dialysis membranes is  consistent with  the  reported  inability of solutions of 
monomers to produce lysis. That hemolysis was not purely related to crystal 
impact  on red cells  is  demonstrated by the occurrence of both lysis and in- 
hibition of lysis in a stationary system. The inhibitor studies (Fig. 4 a  and b) 
clearly showed that PVP  and PVPNO  inhibited all groups. Viscosity effects 
may have been responsible for this in the control and CPPD groups (Fig. 4, 
a and b, contrasted with Fig. 2), but clearly the inhibition of CPPD hemolysis 
is  identical with  that  of the  controls.  EDTA  had  no inhibitory effect. The 
polysaccharides, dextran and heparin, inhibited MSU hemolysis but not that 
of  the  other  groups;  whether  this  represents  binding  of  polysaccharide  to 
urate or to the red cell is not yet known. Inhibition by ellagic acid is probably 
effected by its binding at the receptor sites on the red cell membrane to which 
silica and urate bind; this is not an unexpected finding, since ellagic acid con- 
tains phenolic hydrogen, is a dimer, and is closely related chemically to tannic 
acid which is commonly used to bind proteins to red cells. Finally, plasma is 
capable of inhibiting both silica and urate hemolysis. 
A  technical problem should be mentioned; it is known that hemolytic rate 
is a  function of specific surface (12),  whereas our observations were made on 
the  basis  of  equal  masses.  It  seems  likely that  this  shortcoming probably 
minimizes the hemolytic effect of MSU as compared to silica, as the latter was 
monodispersed, whereas urate crystals tended to aggregate. 
The physicochemical reactivity of the red cell membrane resembles that of 
the lysosomal membrane, based on the similarity of reaction to a  number of 
substances. Agents which produce lysis of both red cells and primary lysosomes 
are vitamin A (19-22), polyene antibiotics (20, 21), lysolecithin (19, 22), strep- 
tolysins S and O  (22),  and weak acids  (23).  But the outer membrane of the 
polymorphonuclear leukocyte appears to be different; it is relatively resistant 
to lysis by weak acids and streptolysins S and O  (24).  One might speculate 
that the incorporation of lysosomal membrane into the inverted outer mem- 
brane (phagosome) results in a phagolysosome with physicochemical properties 
which resemble those of the primary lysosome and red cell. This analogy seems 
quite  clear  for  silica;  in  vitro  hemolysis  and  phagolysosome  rupture,  and 
fibrogenesis in vivo are blocked by PVPNO  (10, 12,  25).  Moreover, a  recent 
electron micrographic study by Schumacher and Phelps directly demonstrated 
that  opsonized  urate  crystals  lyse polymorphonuclear leukocyte phagolyso- 
somes,  subsequently causing  severe  damage  to  the  phagocyte  (26).  Further 110  MEMBRANOLYTIC  EFFECTS  OF  MICROCRYSTALLINE  U'RATE 
support  for  this  concept derives from  the  observation that  phagocytosis  of 
zymosan, heat-killed Bacillus megaterium,  and diamond dust do not result in 
phagolysosome rupture (10,  27). 
We suggest that in gout,  the following sequence of events occurs. Protein- 
coated crystals are phagocytosed, and subsequent fusion of lysosomes with the 
phagosome  produces  a  phagolysosome  that  contains  enzymes.  These  en- 
zymes digest  the  protein coat on the  crystal,  allowing hydrogen bond-medi- 
ated membranolysis to occur. Phagolysosome lysis is  accompanied by the re- 
lease of hydrolytic enzymes into the cytoplasm, resulting in cellular autolysis, 
increased permeability of the outer membrane, and release of enzymes into the 
extracellular medium. This concept does not rule out the possibility of intra- 
cellular crystallization of urate as suggested by Bluhm et al. (9). 
A previously undescribed effect of ellagic acid, inhibition of urate and silica 
hemolysis, has  been  shown.  According to  a  recent  report,  the  formation of 
foreign-body granulomas is blocked by this  agent  (28).  One  wonders if this 
effect might have been due, at least in part, to stabilization of phagolysosomes. 
The striking difference in the effects of MSU and CPPD  on red cell mem- 
branes is consistent with the observed absence of phagolysosomes surrounding 
MSU crystals in gouty effusions, and the frequent finding of CPPD  crystals 
inside  phagosomes in  pseudogout.  This  difference may be  of  importance  in 
understanding other dissimilar features which characterize the pathophysiology 
of inflammation in these two crystal deposition diseases. 
SUMMARY 
Microcrystals  of sodium  urate  produced direct  lysis  of  erythrocyte mem- 
branes,  as  had  been  described previously for silica.  Calcium  pyrophosphate 
crystals induced modest erythrocyte hemolysis, also,  and  time-course experi- 
ments  showed  a  markedly  different reaction  curve from  those  produced  by 
silica and urate. Polyvinylpyridine-N-oxide, a  strong hydrogen acceptor, was 
bound  from solution  to urate  and  silica,  but  not  to  calciunl pyrophosphate 
crystals; this compound effectively blocked urate and silica,  but not calcium 
pyrophosphate  or  control  hemolysis.  Dextran  and  heparin  inhibited  urate- 
but not silica-induced hemolysis. 
If erythrocyte and lysosome membranes react similarly to these particles, 
then the  absence  of phagosomes in  gouty synovial fluid leukocytes, and  the 
presence of these structures in pseudogout, may be explained. 
The authors are indebted to Pierre Jacques, M.D., of Louvain, Belgium who drew their 
attention to the previous mark on the membranolytic  effect of silica. 
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